NCT00048373View on ClinicalTrials.gov

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

April 30, 2004

Conditions
Histiocytosis, Langerhans-Cell
Interventions
DRUG

Etanercept

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

lead

Baylor College of Medicine

OTHER

NCT00048373 - Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL | Biotech Hunter | Biotech Hunter